Media Inquiries: For all MAVA media inquiries, please contact us at 703-506-9300 or email mava@mava.org.
 

 

Check back regularly for news, coverage, and announcements about MAVA.

  

Boston-based Aratana Files for Initial Public Offering

03/22/2013
Aratana Therapeutics, a Kansas City, Kan.-based biopharmaceutical company, which has a key Boston presence at The John Hancock Tower, has filed with the Securities and Exchange Commission for its initial public offering of stock. The company recently raised $10 million in non-dilutive financing from Square 1 Bank.

Read More